Skip to main content
. 2018 Apr 16;5:86. doi: 10.3389/fmed.2018.00086

Table 2.

Clinical and molecular features in pseudoxanthoma elasticum (PXE) patients.

Cases Age Mutations Clinical manifestations
Phenodex Score Other manifestations
Skin (S) Eye (E) Vascular (V) Gastrointestinal (G) Cardiac (C)
PXE 1 27 R1114C
Q378X
Papules Angioid streaks None None None Total score 3
S1/E2/V0/G0/C0
None

PXE 2 27 Del 23–29
Y62H
Laxity Angioid streaks None bleeding None Total score 6
S3/E2/V0/G1/C0
None

PXE 3 33 Del 23–29
Y62H
Laxity Angioid streaks None None None Total score 5
S3/E2/G0/V0/C0
None

PXE 4 33 R1141X
R1141X
Laxity Angioid streaks None None None Total score 5
S3/E2/V0/G0/C0
None

PXE 5 33 R1114C
Q378X
Papules Angioid streaks None None None Total score 3
S1/E2/V0/G0/C0

PXE 6 43 R1141X
R1141X
Laxity Scarring Intermittent claudication None Stroke Total score 10
S3/E3/V2/G0/C2
Hypertension, kidney stones

PXE 7 57 R1114C
Q378X
Laxity Scarring None None None Total score 6
S3/E3/V0/G0/C0
Kidney stones

PXE 8 59 R600H
R1314Q
Papules Scarring None Bleeding None Total score 5
S1/E3/V0/G1/C0
Hypertension, kidney stones